• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

EPAD Co-ordination & Management Team

Serge Van der Geyten

Project Coordinator

Serge Van der Geyten earned a PhD in Sciences and Biology from the Catholic University of Leuven in Belgium. Prior to joining Janssen, he worked for eight years as a Postdoctoral Research Fellow. Serge joined Janssen Pharmaceutica in January 2006 in the Beerse Early Development Medical Writing group. In mid 2014, he accepted a position as Director in the Neuroscience department to lead the IMI EPAD project and ensure timely delivery of the project.

E-mailLinkedin
Craig Ritchie

Project Co-coordinator

Craig Ritchie is an internationally renowned researcher in the field of dementia with a reputation for the design and prosecution of dementia clinical trials, epidemiology of mid-life risk and diagnostic tests. He has been Principal Investigator in almost 30 commercial trials in AD, National Chief Investigator in 15 in the UK and Global Coordinating Investigator on 6. Craig’s skills, credibility and leadership experience make him the ideal person to lead EPAD.

E-mailLinkedin

Governance Structure

General Assembly

ParticipantGA Member
JPNVSerge Van der Geyten
UEDINCraig Richie
UOXFVanessa Raymont
BBRCJosé Luis Molinuevo
SYNAPSECarlos Díaz
KIMiia Kivipelto
VUmcPhilip Scheltens
UCAMCarol Brayne
MRCAdrian Mander
BERRYScott Berry
UNIGEGiovanni Battista Frisoni
RUMCEdo Richard
CUJulie Williams
CHUTBruno Vellas
IQVIALynne Hughes
AEJean Georges
EMCJohan Van Der Lei
APHPBruno Dubois
INSERMKaren Ritchie
ULEICTony Brookes
IXICOMichelle Lax
ARACLONPedro Pesini
FRAUNHOFERMartin Hofmann-Apitius
EISAI-
SARDCaroline Cohen
NOVAna Graf
BIStephane Pollentier
Eli LillyMichael Irizarry
HLUKristian Windfeld
Takeda EUNigel Brayshaw
AC ImmuneGautam Maitra
BiogenJeffrey Sevigny
AmgenHernan Picard
PfizerRachel Schindler
UCBBabak Boroojerdi
RocheRichard Batrla-Utermann
UKKFrank Jessen

Clinical Development Executive

MemberParticipant
Lisa Ford (Chair)
Serge Van Der GeytenJRDBE
Katrin HaeveransJRDBE
Craig RitchieUEDIN
Judi SysonUEDIN
Marise BucukogluUEDIN
Ellie McmasterUEDIN
Kristy DraperUEDIN
José Luís Molinuevo GuixBBRC
Carlos DíazSYNAPSE
Saira RamasastrySYNAPSE
Pieter Jelle VisserVUmc
Scott BerryBERRY
Edo RichardRUMC
Joseph MilneIQVIA
John TraceyIQVIA
Jean GeorgesAE
Sean KnoxBiogen
Gerald LuscanPfizer
Maryline SimonRoche
Frank JessenUK Koeln
Sandra PlaSYNAPSE
Laura Carrera CarballésJRDBE Non-J&J

Executive Committee

ParticipantName
JPNVSerge Van der Geyten
UCBJohannes Streffer
UEDINCraig Ritchie
BBRCJosé Luis Molinuevo
SYNAPSECarlos Díaz (as member of the PMO)
SYNAPSESandra Pla (as member of the PMO)
VUmcPhilip Scheltens
JPNVLaura Carrera Carballés (as member of the PMO)

Project Management Office

ParticipantName
JPNVSerge Van der Geyten
UEDINKristy Draper
JPNVLaura Carrera Carballés
UEDINCraig Ritchie
SYNAPSECarlos Díaz
SYNAPSESandra Pla

National/Regional Leads

ParticipantNameCountry/Region
UEDINCraig RitchieUnited Kingdom
KIMiia KivipeltoThe Nordics
BBRCJosé Luis MolinuevoSpain
VUmcPhilip ScheltensBenelux
UNIGEGiovanni FrisoniSwitzerland/Italy
UKKFrank JessenGermany
CHUTBruno VellasFrance

WP Leads

WPNon-EFPIA LeadEFPIA Lead
WP1Jose Luis Molinuevo (BBRC)
WP2Adrian Mander (MRC)Philip Hougaard (HLU)
WP2Scott Berry (BERRY)Adrian Mander (MRC)
WP3Pieter Jelle Visser (VUmc)Gerald Luscan (Pfizer)
WP4Craig Ritchie (UEDIN)Lisa Ford (JPNV)
WP4Miia Kivipelto (KI)Lisa Ford (JPNV)
WP5Carlos Díaz (SYNAPSE)Serge Van der Geyten (JPNV)
WP6Jean Georges (AE)Sean Knox (Biogen)
WP7José Luis Molinuevo (BBRC)Serge Van der Geyten (JPNV)
WP7Saira Ramasastry (SYNAPSE)
WP8Edo Richard (RUMC)
WP8Carol Brayne (UCAM)

Data Oversight Committee

ParticipantName
JPNVSerge Van der Geyten
JPNVGary Romano
UEDINCraig Ritchie
UEDINJudy Syson
SYNAPSECarlos Díaz
VumcPieter Jelle Visser
UCAMShirlene Badger
MRCAdrian Mander
MRCBrian Tom
BERRYScott Berry
IQVIALynne Hughes
IQVIAAndrea Morton-Morys
EMCJohan van der Lei
ULEICAnthony J. Brookes
ULEICOwen Lancaster
IXICOMark Austin
IXICOKate McLeish
IXICOJohn Hall
IXICOMichelle  Lax
EisaiShobha Dhadda
BICatherine Debove
PfizerGerald Luscan
AridhiaRodrigo Barnes

Publication Approval Committee

Type of institutionParticipantName
EFPIABiogenSean Knox
SMESYNAPSECarlos Díaz
Patient OrganisationAEJean Georges
AcademiaBBRCJosé Luis Molinuevo

Business Leadership Committee

ParticipantNameArea of expertise
BerryScott BerryAnalytics/Consortiums
IQVIABen ConsFinance/Legal
CHUTBruno VellasClinical Leadership
AEJean GeorgesAlliances/Foundation Leadership

Legal and IP Committee

ParticipantName
BBRCGlòria Oliver
UEDINLindsay Hampton
HLUMorten Rosted
JPNVWouter Deneyer

Ethics Advisory Board

NameArea of expertiseOrganisation
Marianne BoeninkPhilosopher of technologyUniversity of Twente
Xavier CarnéClinician/ethicistHospital Clinic’s Clinical Research Ethics Committee
David GoodPsychologyUniversity of Cambridge
Dianne GovePatients’ organisation representativeAlzheimer’s Europe
Jason KarlawishClinician and bioethicistUniversity of Pennsylvania/Penn Memory Centre

Senior Industry Board

OrganisationName
General ElectricBen Newton
General ElectricGill Farrar
Tesella TBC
PiramalAna Catafau
ICONValerie Legrand
ICONKlaudius Siegfried
PPDHeather Bryson
PPDDaniel Burch
PPDDavid Sibbald

International Scientific Synergy Group

NameOrganisation /Charge
Pierre TariotAlzheimer's Prevention Initative
Eric ReimanAlzheimer's Prevention Initative
Jason KarlawishPenn Memory Center, Associate Director (USA) / University of Pennsylvania Professor (USA) / Perelman School of Medicine, Professor (USA)
Lon SchneiderKeck School of Medicine of University of Southern California, Professor of psychiatry, neurology, and gerontology (USA)
Rachelle DoodyBaylor College of Medicine, Effie Marie Cain Chair in Alzheimer's Disease Research, Director of Alzheimer's Disease and Memory Disorders Center (USA)
Reisa SperlingBrigham & Women's Hospital, Director, Center for Alzheimer Research and Treatment (USA) / Massachusetts General Hospital, Principal Investigator, Harvard Aging Brain Study (USA) / Harvard Medical School, Professor (USA)
John MorrisWashington University in St. Louis
Paul AisenAlzheimer's Disease Cooperative Study, Director (USA)
Randy BatemanWashington University School of Medicine, DIAN-TU Director and Principle Investigator / DIAN Clinical Core Leader and Associate Director (USA)
William MobleyUC San Diego School of Medicine, Chair and Distinguished Professor of Neurosciences, Florence Riford Chair for Alzheimer Disease Research (USA)
Colin MastersThe Florey Institute, Senior Deputy Director (Australia) / University of Melbourne, Professor (Australia)
Zaven KachaturianNational Institutes of Health (NIH), Director, Office of Alzheimer's Research (USA) / PAD 2020, Chair and President (USA)
Don BerryUniversity of Texas, MD Anderson Cancer Center, Professor, Department of Biostatistics (USA)
Laura EssermanUniversity of California San Francisco, Director of Carol Franc Buck Breast Care Center, Professor of Surgery and Radiology at UCSF (USA)
Rudi TanziMassachusetts General Hospital, Director, Genetics and Aging Research Unit / Vice-Chair (Research), Department of Neurology / HARVARD MEDICAL SCHOOL, Professor (USA)
Jessica B. LangbaumAlzheimer's Prevention Initiative, Associate Director (USA)
Michael W. WeinerCenter for Imaging of Neurodegenerative Diseases (CIND)
Chris RoweUniversity of Melbourne (Australia)
Maria C. CarrilloAlzheimer's Association, Vice President, Medical & Scientific Relations

Clinical Candidate Selection Committee

ParticipantName
UEDINCraig Ritchie
UOXFChas Bountra
VUmcPhilip Scheltens
GAPRichard Mohs
Latest News
  • Analysis of multiple steroids in saliva in the EPAD study
    2023-03-02
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
    2023-01-16
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
    2022-12-09
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
  • New paper defining and discussing the substantial assets of the EPAD project is out!
    2022-11-23
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

📢@imi_epnd has launched its Cohort Catalogue, a central, open & accessible repository for researchers to discover studies & search metadata. Currently 67 research cohorts from 17 countries across Europe including @IMI_EPAD-VUmc participants ⬇️ eurekalert.org/news-releases/… twitter.com/imi_epnd/statu…

reply retweet favorite
9:56 am · 2023-03-14
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper published in @MetabolitesMDPI using LC-MS/MS method to determine salivary steroids using @IMI_EPAD samples. Congratulations @GregorySarah @zinghomer @guider50 @scottgdenham👏 @EdMassSpecCore @IMI2_NEURONET @IHIEurope #mdpimetabolites mdpi.com/2133518

reply retweet favorite
12:55 pm · 2023-03-02
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Workstream Progress
Workstream 120%
Workstream 232%
Workstream 310%
Workstream 446%
Contact us

Submitclear

Recent Posts
  • Analysis of multiple steroids in saliva in the EPAD study
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
  • Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
  • New paper defining and discussing the substantial assets of the EPAD project is out!
Recent Comments
  • The EPAD genomic data is now available on the Alzheimer’s Disease Workbench on The EPAD genomic data is now available on the Alzheimer’s Disease Workbench
  • ADDI celebrates one year of achievements – Neuronet on ADDI celebrates one year of achievements
  • EPAD dataset is now available on the Alzheimer’s Disease Workbench on The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
  • The final EPAD dataset is now available to the entire research community on The final EPAD dataset is now available to the entire research community
  • The ERC has awarded an ERC grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease – Neuronet on New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease
Archives
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
Categories
  • EPAD Academy
  • News
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT